← GSK plc

Annual Trend FY 2016 FY 2017 FY 2018 FY 2019 FY 2020 FY 2021 FY 2022 FY 2023 FY 2024 FY 2025
Total Revenue $27.9b $30.2b $30.8b $33.8b $34.1b $34.1b $29.3b $30.3b $31.4b $32.7b
Cost of Goods and Services Sold $9.3b $10.3b $10.2b $11.9b $11.7b $11.6b $9.6b $8.6b $9.0b $9.0b
Gross Profit $18.6b $19.8b $20.6b $21.9b $22.4b $22.5b $19.8b $21.8b $22.3b $23.6b
Research and development $3.6b $4.5b $3.9b $4.6b $5.1b $5.3b $5.5b $6.2b $6.4b $7.5b
Additional Financial Items
Applicable Tax Rate $0 $0 $0 $0 $0 $0 $0 — — —
Auditors Remuneration For Tax Services $200k $200k $100k — — — — — — —
Average Effective Tax Rate $0 $0 $0 $0 $0 $0 $0 $0 $0 $0
Depreciation Right of Use Assets — — — $214.0m $225.0m $213.0m $176.0m $190.0m $211.0m $206.0m
Finance Income $72.0m $65.0m $81.0m $98.0m $44.0m $28.0m $76.0m $115.0m $122.0m $169.0m
Impairment Loss Recognised In Profit Or Loss Goodwill — — — $4.0m — — — — — —
Impairment Loss Recognised In Profit Or Loss Intangible Assets Other Than Goodwill $22.0m $690.0m $134.0m $126.0m $257.0m — — — $317.0m $888.0m
Impairment Loss Reversal Of Impairment Loss Recognised In Profit Or Loss — — — — — — — — ($12.0m) $4.0m
Other Income $23.0m $9.0m ($7.0m) — — — — — — —
Profit Loss Attributable To Noncontrolling Interests $150.0m $637.0m $423.0m $623.0m $639.0m $711.0m $665.0m $380.0m $376.0m $573.0m
Profit Loss Attributable To Owners Of Parent $912.0m $1.5b $3.6b $4.6b $5.7b $4.4b $15.0b $4.9b $2.6b $5.7b
Profit Loss Before Tax $1.9b $3.5b $4.8b $6.2b $7.0b $5.4b $5.6b $6.1b $3.5b $7.4b
Profit Loss From Operating Activities $2.6b $4.1b $5.5b $7.0b $7.8b $6.2b $6.4b $6.7b $4.0b $7.9b
Share Of Profit Loss Of Associates And Joint Ventures Accounted For Using Equity Method $5.0m $13.0m $31.0m $74.0m $33.0m $33.0m ($2.0m) ($5.0m) ($3.0m) $1.0m
Tax Rate Effect Of Foreign Tax Rates $0 $0 $0 $0 $0 $0 $0 $0 $0 ($0)
Basic Earnings (Loss) Per Share $0.19 $0.31 $0.74 $0.94 $1.16 $0.88 $3.71 $1.22 $0.63 $1.41
Diluted Earnings (Loss) Per Share $0.19 $0.31 $0.73 $0.93 $1.14 $0.87 $3.66 $1.20 $0.62 $1.39
Selling, General and Administrative Expense $9.4b $9.7b $9.9b $11.4b $11.5b $11.0b $8.4b $9.4b $11.0b $9.1b
Deferred Tax Expense (Income) ($541.0m) ($263.0m) ($414.0m) ($183.0m) ($693.0m) ($1.0b) ($784.0m) ($865.0m) ($1.0b) ($283.0m)
Deferred Tax Expense (Income) Recognised In Profit Or Loss — $247.0m $396.0m — — — — — — —
Depreciation And Amortisation Expense $1.8b $1.9b $1.9b $2.3b $2.4b $2.4b $2.1b $2.3b $2.6b $2.3b
Employee Benefits Expense $8.2b $9.1b $9.4b $9.9b $10.2b $9.0b $7.7b $8.5b $8.8b $8.8b
Expense From Share-Based Payment Transactions With Employees $338.0m $347.0m $393.0m $432.0m $393.0m $404.0m $314.0m $321.0m $347.0m $390.0m
Expense Relating To Leases Of Low-Value Assets For Which Recognition Exemption Has Been Used — — — $4.0m $5.0m $3.0m $2.0m $2.0m $2.0m —
Expense Relating To Short-Term Leases For Which Recognition Exemption Has Been Used — — — $12.0m $11.0m $7.0m $6.0m $8.0m $13.0m —
Expense Relating To Variable Lease Payments Not Included In Measurement Of Lease Liabilities — — — $13.0m $11.0m $10.0m $9.0m $17.0m $15.0m —
Finance Costs $736.0m $734.0m $798.0m $912.0m $892.0m $784.0m $879.0m $792.0m $669.0m $701.0m
Other Operating Income Expense ($3.4b) ($2.0b) ($1.6b) $689.0m $1.6b ($476.0m) ($235.0m) ($363.0m) ($1.5b) $16.0m
Postemployment Benefit Expense Defined Benefit Plans — — — — — — — — $218.0m $170.0m
Postemployment Benefit Expense Defined Contribution Plans — — — — — — — — $150.0m $130.0m
Interest Expense — — — — — $775.0m $912.0m — — —
Interest Expense On Lease Liabilities — — — $39.0m $40.0m $31.0m $30.0m $38.0m $46.0m $46.0m
Income Tax Expense Continuing Operations $877.0m $1.4b $754.0m $953.0m $580.0m $346.0m $707.0m $756.0m $526.0m $1.1b

Data sourced from SEC EDGAR 10-K filings via EdgarTools. Amounts are shown in USD as reported in each fiscal year filing.

Values abbreviated: b = billions, m = millions, k = thousands. Per share data in USD.